Clinical Trial Information Request for Protocol 2024P000986 Title A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T-cells (CABA-201) in Participants with Generalized Myasthenia Gravis (CAB-201-004) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone